Provexis plc (AIM:PXS)
London · Delayed Price · Currency is GBP · Price in GBX 0.9400
+0.0150 (1.62%)
Oct 1, 2026, 4:35 PM GMT
Provexis Market Cap
Provexis has a market cap or net worth of 21.7 million as of October 1, 2026. Its market cap has increased by 49.92% in one year.
Market Cap
21.70M
Enterprise Value
20.64M
Revenue
871.27K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.94
ChartMarket Cap Chart
Since September 7, 2005, Provexis's market cap has increased from 2.24M to 21.70M, an increase of 867.76%. That is a compound annual growth rate of 11.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 21.70M | 2.78% |
| Dec 31, 2025 | 21.11M | 33.33% |
| Dec 31, 2024 | 15.83M | 9.84% |
| Dec 29, 2023 | 14.42M | -10.34% |
| Dec 30, 2022 | 16.08M | -6.76% |
| Dec 31, 2021 | 17.24M | -2.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Haleon | 29.69B |
| Hikma Pharmaceuticals | 3.38B |
| HUTCHMED (China) | 1.87B |
| Allergy Therapeutics | 300.80M |
| ECO Animal Health Group | 66.40M |
| Shield Therapeutics | 59.92M |
| Hellenic Dynamics | 1.32M |
| Chill Brands Group | 915.12K |